Related Experiment Video
Updated: Apr 21, 2026

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
14.9K
Competition in liver transplantation: helpful or harmful?
Reza F Saidi1, Moaven Razavi, A Benedict Cosimi
1Division of Organ Transplantation, Department of Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI.
Summary
Increased competition among liver transplant centers due to organ shortages leads to higher-risk patients and marginal organs. Re-evaluation of practices and standardized guidelines are crucial for fair organ allocation.
Area of Science:
- Medicine
- Transplantation Biology
- Organ Donation
Background:
- Improved liver transplantation outcomes have increased the number of US transplant centers and patients awaiting transplants.
- A significant and growing shortage of donor organs has intensified competition among transplant centers nationwide.
- This competition has been linked to the acceptance of higher-risk patients and the use of less optimal liver allografts.
Purpose of the Study:
- To highlight the consequences of increased competition in liver transplantation.
- To advocate for a re-evaluation of current practices in patient selection and organ utilization.
- To promote the development of innovative strategies for organ allocation and standardization of candidate evaluation.
Main Methods:
- Review of current trends and practices in US liver transplant centers.
- Analysis of reports documenting patient listing and allograft utilization patterns.
- Discussion of the ethical and logistical challenges in organ allocation.
Main Results:
- Competition among transplant centers has resulted in the listing of sicker patients.
- Marginal liver allografts are being increasingly utilized due to organ scarcity.
- Disparities in evaluation and listing guidelines may exist across different transplant centers.
Conclusions:
- The transplant community must critically assess the impact of competition on patient selection and organ use.
- Innovative approaches are needed to ensure equitable and trustworthy organ allocation.
- Nationwide conformity in guidelines for evaluating and listing liver transplant candidates is essential.
Related Concept Videos
Kidney Transplant I: Introduction
808
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
808
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant II: Surgical Procedure
899
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
899
Bone Marrow Sampling and Transplants
2.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K

